Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Stopped The trial was terminated early due to slow recruitment.
Conditions
- Human Immunodeficiency Virus
Sponsor
Merck Sharp & Dohme LLC